Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Shaw

Showing results (571-580 of 742) with videos related to

Pageof 75
Sort By:
Science Advances|December 27, 2018
Ocean deoxygenation and zooplankton: Very small oxygen differences matterK F Wishner, B A Seibel, C Roman, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 23, 2016
Combined Pan-HER and ALK/ROS1/MET Inhibition with Dacomitinib and Crizotinib in Advanced Non-Small Cell Lung Cancer: Results of a Phase I StudyPasi A Jänne, Alice T Shaw, D Ross Camidge, et al.
Medical Care|April 1, 1990
Using relative productivity assessments for allocating housestaff to departmentsM F Roizen, K F Brown, M L Marais, et al.
Lung Cancer (Amsterdam, Netherlands)|July 24, 2018
Clinical outcomes of patients with resected, early-stage ALK-positive lung cancerJamie E Chaft, Ibiayi Dagogo-Jack, Fernando C Santini, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 14, 2017
Circulating Tumor DNA Identifies EGFR Coamplification as a Mechanism of Resistance to Crizotinib in a Patient with Advanced MET-Amplified Lung AdenocarcinomaIbiayi Dagogo-Jack, David Fabrizio, Jochen Lennerz, et al.
Immunologic Research|December 28, 2013
Induction of bone loss in DBA/1J mice immunized with citrullinated autologous mouse type II collagen in the absence of adjuvantAnand Dusad, Michael J Duryee, Anita T Shaw, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 24, 2018
Activity of the Hsp90 inhibitor luminespib among non-small-cell lung cancers harboring EGFR exon 20 insertionsZ Piotrowska, D B Costa, G R Oxnard, et al.
European Journal of Dental Education : Official Journal of the Association for Dental Education in Europe|October 12, 2012
Evaluate, assess, treat: development and evaluation of the EAT framework to increase effective communication regarding sensitive oral-systemic health issuesR D DeBate, D Cragun, A A Gallentine, et al.
The Biochemical Journal|May 1, 1997
Synthetic, structural and biological studies of the ubiquitin system: synthesis and crystal structure of an analogue containing unnatural amino acidsS G Love, T W Muir, R Ramage, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 22, 2019
Molecular Analysis of Plasma From Patients With ROS1-Positive NSCLCIbiayi Dagogo-Jack, Marguerite Rooney, Rebecca J Nagy, et al.
Pageof 75

Showing results (571-580 of 742) with videos related to

Sort By:
Pageof 75
Science Advances|December 27, 2018
Ocean deoxygenation and zooplankton: Very small oxygen differences matterK F Wishner, B A Seibel, C Roman, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 23, 2016
Combined Pan-HER and ALK/ROS1/MET Inhibition with Dacomitinib and Crizotinib in Advanced Non-Small Cell Lung Cancer: Results of a Phase I StudyPasi A Jänne, Alice T Shaw, D Ross Camidge, et al.
Medical Care|April 1, 1990
Using relative productivity assessments for allocating housestaff to departmentsM F Roizen, K F Brown, M L Marais, et al.
Lung Cancer (Amsterdam, Netherlands)|July 24, 2018
Clinical outcomes of patients with resected, early-stage ALK-positive lung cancerJamie E Chaft, Ibiayi Dagogo-Jack, Fernando C Santini, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 14, 2017
Circulating Tumor DNA Identifies EGFR Coamplification as a Mechanism of Resistance to Crizotinib in a Patient with Advanced MET-Amplified Lung AdenocarcinomaIbiayi Dagogo-Jack, David Fabrizio, Jochen Lennerz, et al.
Immunologic Research|December 28, 2013
Induction of bone loss in DBA/1J mice immunized with citrullinated autologous mouse type II collagen in the absence of adjuvantAnand Dusad, Michael J Duryee, Anita T Shaw, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 24, 2018
Activity of the Hsp90 inhibitor luminespib among non-small-cell lung cancers harboring EGFR exon 20 insertionsZ Piotrowska, D B Costa, G R Oxnard, et al.
European Journal of Dental Education : Official Journal of the Association for Dental Education in Europe|October 12, 2012
Evaluate, assess, treat: development and evaluation of the EAT framework to increase effective communication regarding sensitive oral-systemic health issuesR D DeBate, D Cragun, A A Gallentine, et al.
The Biochemical Journal|May 1, 1997
Synthetic, structural and biological studies of the ubiquitin system: synthesis and crystal structure of an analogue containing unnatural amino acidsS G Love, T W Muir, R Ramage, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 22, 2019
Molecular Analysis of Plasma From Patients With ROS1-Positive NSCLCIbiayi Dagogo-Jack, Marguerite Rooney, Rebecca J Nagy, et al.
Pageof 75